Factor XI Inhibition: Adult Evidence and Paediatric Considerations
Hämostaseologie · 2026-10 · 46 (05) · 326-335
DOI: 10.1055/a-2918-8066 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Hämostaseologie, online erschienen am 07.08.2026. Verfasst von Susanne Holzhauer und 1 weiteren Autor:innen. Beteiligte Einrichtung: Charité - Universitätsmedizin Berlin, Department of Paediatric Haematology and Oncology, BE, Germany, Berlin. Hauptthemen laut MEDLINE: Anticoagulants, Factor XI, Hemorrhage. Die Arbeit nennt 69 Literaturangaben.
Abstract (Originalsprache)
Factor XI (FXI) inhibition represents an innovative approach to anticoagulation, offering the potential for effective thromboprophylaxis with a reduced risk of bleeding. While intensive clinical research is underway in adult populations, its relevance to the treatment of children remains largely unknown. The evidence base to inform potential paediatric use is still limited, and the extent to which findings from adult studies can be translated to paediatric care has yet to be clarified. This review systematically maps the existing evidence from preclinical and adult studies on FXIa and examines its implications for future paediatric application and treatment strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Charité - Universitätsmedizin Berlin, Department of Paediatric Haematology and Oncology, BE, Germany, Berlin.
- Medical University of Vienna, Department of Paediatrics and Adolescent Medicine, Vienna, Austria, Vienna.
ORCID-Profile: Susanne Holzhauer
Zitieren
APA
Holzhauer, S., & Male, C. (2026). Factor XI Inhibition: Adult Evidence and Paediatric Considerations. Hämostaseologie, 46(05), 326-335. https://doi.org/10.1055/a-2918-8066
Vancouver
Holzhauer S, Male C. Factor XI Inhibition: Adult Evidence and Paediatric Considerations. Hämostaseologie. 2026;46(05):326-335. doi:10.1055/a-2918-8066
BibTeX
@article{Holzhauer2026,
author = {Holzhauer, Susanne and Male, Christoph},
title = {Factor XI Inhibition: Adult Evidence and Paediatric Considerations},
journal = {Hämostaseologie},
year = {2026},
volume = {46},
number = {05},
pages = {326--335},
doi = {10.1055/a-2918-8066}
}
EUVIMED